Xartec Salut at HLTH 2025: New US HealthTech Collaboration & Expansion

Catalonia is strengthening its position in the global health innovation landscape through a new international collaboration initiative. The Xartec Salut team, spearheaded by the Institut de Recerca i Innovació en Salut (IRIS) of the Universitat Politècnica de Catalunya (UPC), recently engaged with international leaders at a major health conference, leading to a significant partnership.

Expanding Global Reach

The Xartec Salut team participated in HLTH 2025 in Las Vegas, a conference that drew over 12,000 attendees and 400 speakers from across the healthcare sector. During the event, the team observed advancements in healthcare systems worldwide, particularly in areas like artificial intelligence applied to health, personalized medicine, mental health, and longevity.

Strategic Partnerships Forged

These interactions facilitated strategic meetings with key institutions and actors in the international ecosystem, focused on identifying opportunities for collaboration and technology transfer. A direct outcome of these meetings is the establishment of a U.S. Exchange program, coordinated with the Spanish Embassy.

Did You Know? HLTH 2025 brought together over 12,000 participants and 400 speakers from hospitals, startups, investors, and global hubs.

The exchange program, slated to begin development in 2026, aims to foster talent mobility, the development of joint projects, and the promotion of collaborations with leading entities in the North American HealthTech sector. This initiative is expected to enhance the international visibility of Catalan research.

Xartec Salut Open HealthTech Project

This program falls under the umbrella of the Xartec Salut Open HealthTech project, a broader initiative designed to build a global network for collaboration and technology transfer. Open HealthTech intends to forge partnerships globally, encouraging joint projects, knowledge sharing, and opportunities for both industrial and clinical advancements.

Expert Insight: The establishment of an exchange program with the U.S. Represents a strategic move to leverage North American expertise and investment in the rapidly evolving HealthTech sector, potentially accelerating the development and adoption of Catalan innovations.

Through these efforts, Xartec Salut is reinforcing its dedication to health technology innovation, internationalization of projects, and the effective transfer of scientific knowledge to society, with the goal of positively impacting healthcare systems worldwide.

Frequently Asked Questions

What is the Xartec Salut Open HealthTech project?

The Xartec Salut Open HealthTech project is a strategic international initiative aimed at consolidating a global collaboration network, facilitating technology transfer, and positioning Catalonia as a worldwide health innovation hub.

When will the U.S. Exchange program begin development?

The U.S. Exchange program will begin development in 2026, following its establishment in coordination with the Spanish Embassy.

What areas of healthcare are being prioritized for innovation?

The Xartec Salut team observed advancements in artificial intelligence applied to health, personalized medicine, mental health, and longevity during their time at HLTH 2025.

How might increased international collaboration impact the future of healthcare innovation?